SEC Filing | Amkor Technology

View:

SEC FORM 5 SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

KIM SUSAN Y

(Last)

(First)

(Middle)

C/O SIANA CARR O'CONNOR & LYNAM,

1500 EAST LANCASTER AVENUE

(Street)

PAOLI

19301-9713

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AMKOR TECHNOLOGY, INC. [ AMKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
See Exhibit 99.1

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2020

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/02/2020		G⁽¹⁾	91,392	D	$10.28	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	03/16/2020		G⁽²⁾	15,641	D	$7.47	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	03/16/2020		G⁽²⁾	15,641	A	$7.47	4,638,381⁽⁸⁾⁽⁹⁾⁽¹⁰⁾	D
Common Stock	05/26/2020		G⁽³⁾	1,564,323	A	$10.33	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	08/21/2020		G⁽⁴⁾	561,343	D	$12.71	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	08/21/2020		G⁽⁴⁾	561,343	A	$12.71	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	12/15/2020		G⁽⁵⁾	727,169	D	$15.4	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock	12/15/2020		G⁽⁶⁾	446,316	D	$15.4	32,339,816⁽⁷⁾	I	By self as trustee
Common Stock							25,674,640⁽⁷⁾	I	By self as GP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On March 2, 2020, the James J. Kim Qualified Annuity Trust U/A Dated 10/13/14 distributed 91,392 shares of the Issuer's Common Stock to James J. Kim. James J. Kim and Susan Y. Kim are co-trustees.

2. On March 16, 2020, the James J. Kim Qualified Annuity Trust U/A Dated 10/13/14 distributed 15,641 shares of the Issuer's Common Stock to each of Susan Y. Kim, John T. Kim and David D. Kim. James J. Kim and Susan Y. Kim are co-trustees.

3. On May 26, 2020, James J. Kim transferred 1,564,323 shares of the Issuer's Common Stock to the James J. Kim 2020-1 Qualified Annuity Trust under the James J. Kim 2020-1 Qualified Annuity Trust Agreement dated 4/1/20. Susan Y. Kim and James J. Kim are co-trustees.

4. On August 21, 2020, the Susan Y. Kim 2015 Irrevocable Trust U/A Dated 3/16/15 distributed 561,343 shares of the Issuer's Common Stock to the Family Trust Under the Susan Y. Kim 2012 Irrevocable Trust Agreement Dated 7/26/12. Susan Y. Kim and John T. Kim are co-trustees of both of the trusts.

5. On December 15, 2020, the James J. Kim 2019-1 Qualified Annuity Trust U/A Dated 9/10/19 distributed 727,169 shares of the Issuer's Common Stock to James J. Kim. James J. Kim and Susan Y. Kim are co-trustees of the trust.

6. On December 15, 2020, the James J. Kim 2018-1 Qualified Annuity Trust U/A Dated 8/30/18 distributed 446,316 shares of the Issuer's Common Stock to James J. Kim. James J. Kim and Susan Y. Kim are co-trustees of the trust.

7. The reporting person may be deemed to indirectly own 27,717,773 shares of the Issuer's Common Stock held by various family trusts of which the reporting person is a trustee, 4,622,043 shares of the Issuer's Common Stock held by grantor retained annuity trusts (see footnote 9), and 25,674,640 shares of the Issuer's Common Stock held by limited partnerships established for the benefit of members of the James J. Kim family of which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities, except to the extent of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities, except to the extent of the reporting person's pecuniary interest therein, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

8. Includes options to acquire 125,000 shares of the Issuer's Common Stock.

9. On April 1, 2020, the reporting person gifted 3,000,000 shares of the Issuer's Common Stock to the Qualified Annuity Trust Under the Susan Y. Kim 2020-1 Irrevocable Trust Agreement Dated 04/01/20. Susan Y. Kim and James J. Kim are co-trustees of the trust. On August 19, 2020, the Susan Y. Kim 2015 Irrevocable Trust U/A Dated 3/16/15 distributed 526,500 shares of the Issuer's Common Stock to the reporting person. Susan Y. Kim and John T. Kim are co-trustees of the trust. On December 15, 2020, the Qualified Annuity Trust under the Susan Y. Kim 2018-1 Irrevocable Trust Agreement Dated 8/29/18 distributed 162,257 shares of the Issuer's Common Stock to the reporting person. James J. Kim and Susan Y. Kim are co-trustees of the trust.

10. (Continued From Footnote 9) Each of the aforementioned trusts to which the reporting person transferred shares of the Issuer's Common Stock or from which the reporting person received such shares is a grantor retained annuity trust of which the reporting person is the settlor, the sole current beneficiary and a co-trustee. Pursuant to the Form 5 instructions, in her capacity as a co-trustee of the trusts, the reporting person is being treated as having a pecuniary interest in all of the shares held by such trusts. Accordingly, transfers between the reporting person and such trusts result in mere changes from direct to indirect ownership or vice versa. Such transfers are therefore not reported on this Form 5. On December 31, 2020, such grantor retained annuity trusts held 4,622,043 shares of the Issuer's Common Stock.

Remarks:

	/s/ Mark N. Rogers, as Attorney in Fact	02/12/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.



	 Know all by these presents, that the undersigned hereby makes, constitutes
 and appoints Mark N. Rogers and John D. Montanti (either of whom may act
 individually) as the undersigned's true and lawful attorney-in-fact, with full
 power and authority as hereinafter described on behalf of and in the name,
 place and stead of the undersigned to:

(1)    prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
(including any amendments thereto) with respect to the securities of Amkor
Technology, Inc., a Delaware corporation (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");

(2)    seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to release
any such information to the undersigned and approves and ratifies any such
release of information; and

(3)    perform any and all other acts which in the discretion of such attorney-
in-fact are necessary or desirable for and on behalf of the undersigned in
connection with the foregoing.

The undersigned acknowledges that:

(1)    this Power of Attorney authorizes, but does not require, such attorney-
in-fact to act in their discretion on information provided to such attorney-in-
fact without independent verification of such information;

(2)    any documents prepared and/or executed by such attorney-in-fact on behalf
 of the undersigned pursuant to this Power of Attorney will be in such form and
 will contain such information and disclosure as such attorney-in-fact, in his
 or her discretion, deems necessary or desirable;

(3)    neither the Company nor such attorney-in-fact assumes (i) any liability
for the undersigned's responsibility to comply with the requirements of the
Exchange Act, (ii) any liability of the undersigned for any failure to comply
with such requirements, or (iii) any obligation or liability of the undersigned
for profit disgorgement under Section 16(b) of the Exchange Act; and

(4)    this Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act.

       The undersigned hereby gives and grants the foregoing attorney-in-fact
full power and authority to do and perform all and every act and thing
whatsoever requisite, necessary or appropriate to be done in and about the
foregoing matters as fully to all intents and purposes as the undersigned might
or could do if present, hereby ratifying all that such attorney-in-fact of, for
and on behalf of the undersigned, shall lawfully do or cause to be done by
virtue of this Limited Power of Attorney.

       This Power of Attorney shall remain in full force and effect until
revoked by the undersigned in a signed writing delivered to such attorney-in-
fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
 be executed as of this 10th day of February, 2021.






 /s/ Susan Y. Kim
---------------------
 Susan Y. Kim

Exhibit 99.1

A Schedule 13D was filed by James J. Kim and those members of the reporting
group who then constituted the group on November 28, 2005, as amended by
Amendment No. 1 filed with the Securities and Exchange Commission (the
"Commission") on April 4, 2008, Amendment No. 2 filed with the Commission on
March 19, 2009, Amendment No. 3 filed with the Commission on April 16, 2009,
Amendment No. 4 filed with the Commission on February 5, 2010, Amendment No. 5
filed with the Commission on March 28, 2011, Amendment No. 6 filed with the
Commission on November 17, 2011, Amendment No. 7 filed with the Commission on
March 29, 2013, Amendment No. 8 filed with the Commission on March 28, 2014,
Amendment No. 9 filed with the Commission on March 30, 2015, Amendment No. 10
filed with the Commission on March 30, 2016, Amendment No. 11 filed with the
Commission on January 20, 2017, Amendment No. 12 filed with the Commission on
March 21, 2018, Amendment No. 13 filed with the Commission on November 9, 2018,
Amendment No. 14 filed with the Commission on March 20, 2020 (as further amended
from time to time, the "Schedule 13D").  Those individuals and entities listed
in the Schedule 13D, including the filer of this Form 5, may be deemed to be
members of a group (the "Group") who each exercise voting or investment power
with respect to shares of Amkor Technology, Inc.'s (the "Issuer") Common Stock
in concert with other members of the Group.  The Group may be deemed to
beneficially own more than 10% of the outstanding voting securities of the
Issuer. The reporting person states that the filing of this Form 5 Report shall
not be deemed an admission that the reporting person is the beneficial owner of
the reported securities owned by the other members of the Group, for the purpose
of Section 16 of the Securities Exchange Act of 1934, as amended, or for any
other purpose.